These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30926526)

  • 41. In vitro effects of alginate lyase SG4 + produced by Paenibacillus lautus alone and combined with antibiotics on biofilm formation by mucoid Pseudomonas aeruginosa.
    Kanwar K; Sharma D; Singh H; Pal M; Bandhu R; Azmi W
    Braz J Microbiol; 2024 Jun; 55(2):1189-1203. PubMed ID: 38705960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.
    Günday Türeli N; Torge A; Juntke J; Schwarz BC; Schneider-Daum N; Türeli AE; Lehr CM; Schneider M
    Eur J Pharm Biopharm; 2017 Aug; 117():363-371. PubMed ID: 28476373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
    Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD
    Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
    Lababidi N; Ofosu Kissi E; Elgaher WAM; Sigal V; Haupenthal J; Schwarz BC; Hirsch AKH; Rades T; Schneider M
    J Control Release; 2019 Nov; 314():62-71. PubMed ID: 31654686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ambroxol inhibits mucoid conversion of Pseudomonas aeruginosa and contributes to the bactericidal activity of ciprofloxacin against mucoid P. aeruginosa biofilms.
    Wang W; Yu J; He Y; Wang Z; Li F
    APMIS; 2016 Jul; 124(7):611-8. PubMed ID: 27102839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial activity of mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa.
    Tetz G; Vikina D; Tetz V
    Ann Clin Microbiol Antimicrob; 2016 Mar; 15():19. PubMed ID: 27001074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis of biofilm infections in cystic fibrosis patients.
    Høiby N; Bjarnsholt T; Moser C; Jensen PØ; Kolpen M; Qvist T; Aanaes K; Pressler T; Skov M; Ciofu O
    APMIS; 2017 Apr; 125(4):339-343. PubMed ID: 28407432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa.
    Alipour M; Dorval C; Suntres ZE; Omri A
    J Pharm Pharmacol; 2011 Aug; 63(8):999-1007. PubMed ID: 21718282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fucoidan coated ciprofloxacin loaded chitosan nanoparticles for the treatment of intracellular and biofilm infections of Salmonella.
    S E; T R N; V K R; Baranwal G; Biswas R; R J; S S
    Colloids Surf B Biointerfaces; 2017 Dec; 160():40-47. PubMed ID: 28922635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
    Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
    Tewes F; Bahamondez-Canas TF; Smyth HDC
    AAPS PharmSciTech; 2019 May; 20(5):205. PubMed ID: 31144198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Combined Ciprofloxacin and azithromycin free and nano formulations to control biofilm producing Pseudomonas aeruginosa isolated from burn wounds.
    Raouf M; Essa S; El Achy S; Essawy M; Rafik S; Baddour M
    Indian J Med Microbiol; 2021 Jan; 39(1):81-87. PubMed ID: 33460732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
    García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R
    Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y; Huang J; Li L; Liu L
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ciprofloxacin plus erythromycin or ambroxol ameliorates endotracheal tube-associated Pseudomonas aeruginosa biofilms in a rat model.
    Cheng C; Du L; Yu J; Lu Q; He Y; Ran T
    Pathol Res Pract; 2015 Dec; 211(12):982-8. PubMed ID: 26601615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.